Is MKL a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for Markel Group (MKL) rests on Specialty underwriting discipline: The insurance segment focuses on specialty and excess-and-surplus lines where pricing and terms are less commoditized. Revenue (TTM) is ~$15B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Reported earnings are volatile because unrealized investment gains and losses run through the income statement, so a down market can produce a headline net loss (as in Q1 2026) even with solid underwriting. Whether MKL is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Markel Group Inc. is a Virginia-based holding company built on three engines: a specialty property and casualty insurance operation that underwrites hard-to-place and niche risks (from executive liability to equine coverage), an investment portfolio funded largely by insurance float, and Markel Ventures, a group of wholly owned operating businesses spanning industrial, consumer, and services companies. The insurance business generates premiums and, ideally, an underwriting profit, while the float is invested in equities and fixed income to compound over time. This design is why MKL is frequently described as a mini Berkshire Hathaway. The investment picture centers on long-term growth in book value per share rather than quarterly earnings smoothness. Reported results are lumpy because net investment gains and losses flow through earnings, so a strong equity market inflates results and a weak one can produce headline net losses even when underwriting is healthy. In Q1 2026 operating performance held up (the insurance combined ratio improved), but a swing in investment marks drove a reported net loss, and activist investor JANA Partners has publicly pressed the board to divest Markel Ventures and launch a large buyback, arguing the conglomerate structure obscures the value of the core insurer.
What's the case for buying MKL?
1. Specialty underwriting discipline
The insurance segment focuses on specialty and excess-and-surplus lines where pricing and terms are less commoditized. In Q1 2026 the combined ratio improved to roughly 93% from 96% a year earlier, meaning the business kept more than it paid out in claims and expenses. Sustained sub-100 combined ratios are the foundation of the compounding model.
2. Investment portfolio and float
Insurance float lets Markel invest premiums before claims are paid, and the portfolio blends fixed income with a long-held equity book. Rising rates lift recurring investment income while the equity sleeve ties reported results to public markets. This is the second engine that has historically driven book-value growth.
3. Markel Ventures and capital allocation
Markel Ventures owns a diversified set of operating businesses whose cash flows fund further investment. Management has historically framed Ventures as a permanent home for good businesses, though results across industrial and other units can vary with the economic cycle.
4. Activist-driven simplification
JANA Partners has publicly urged the board to separate or sell Markel Ventures and launch a roughly $2.0 billion tender offer, arguing the current structure weighs on returns. Any move toward a simpler insurer-plus-investments model, or a large buyback, could reshape how the market values the shares.
What are the risks to MKL?
Reported earnings are volatile because unrealized investment gains and losses run through the income statement, so a down market can produce a headline net loss (as in Q1 2026) even with solid underwriting. Insurance results are exposed to catastrophe losses, reserve development, and reinsurance pricing, any of which can push the combined ratio above 100%. The conglomerate structure invites the JANA activist campaign, and the outcome is uncertain: a breakup could unlock value or could disrupt the long-term compounding model. The stock is thinly traded per share at a very high nominal price with only about 12.5 million shares outstanding, and premium and revenue growth has been muted recently.
How is MKL valued? (as of JULY 2026)
Snapshot for MKL as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$15B
- Q1 2026 revenue: ~$3.55B
- Market cap: ~$23B
- Book value per share: ~$1,447
- P/E ratio: ~13x
- Shares outstanding: ~12.5M
MKL trades around a low-to-mid teens price-to-earnings multiple and near a modest premium to its roughly $1,447 book value per share, valuation anchors that matter more than headline EPS given the volatility of investment marks. Consensus 2026 EPS estimates were trimmed (from about $159 toward the low $140s) after a soft first quarter, and the reported Q1 2026 net loss reflected investment swings rather than a collapse in underwriting. Figures are approximate and move with markets and reserve updates.
How do you decide if MKL is a buy?
Rather than asking whether MKL is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold MKL indirectly through an index or sector ETF before adding more.
For the full picture, see the MKL stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about MKL against your real portfolio and see your actual exposure before deciding.
The bottom line on MKL
The bottom line: Markel Group's story right now is Specialty underwriting discipline, with revenue (ttm) at ~$15B. If you believe that narrative continues, the call is about sizing MKL sensibly and checking overlap with what you own; if you doubt it (the risk: reported earnings are volatile because unrealized investment gains and losses run through the income statement, so a down market can produce a headline net loss (as in Q1 2026) even with solid underwriting.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around MKL with Walnut
Use Markel Group as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is MKL a good stock to buy right now?
+
The case for Markel Group right now is Specialty underwriting discipline, with revenue (ttm) at ~$15B. If you believe that thesis holds, MKL is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is reported earnings are volatile because unrealized investment gains and losses run through the income statement, so a down market can produce a headline net loss (as in Q1 2026) even with solid underwriting. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Markel Group do?
+
Markel Group Inc.
What are the main risks of MKL?
+
Reported earnings are volatile because unrealized investment gains and losses run through the income statement, so a down market can produce a headline net loss (as in Q1 2026) even with solid underwriting. Insurance results are exposed to catastrophe losses, reserve development, and reinsurance pricing, any of which can push the combined ratio above 100%. The conglomerate structure invites the JANA activist campaign, and the outcome is uncertain: a breakup could unlock value or could disrupt the long-term compounding model. The stock is thinly traded per share at a very high nominal price with only about 12.5 million shares outstanding, and premium and revenue growth has been muted recently.
What does Markel Group do?
+
Markel Group is a holding company with three engines: specialty property and casualty insurance, an investment portfolio funded by insurance float, and Markel Ventures, a group of wholly owned operating businesses across various industries.
Why is Markel called a mini Berkshire Hathaway?
+
Like Berkshire, Markel uses insurance premiums (float) to fund a long-term investment portfolio and owns a diversified set of operating businesses, with a stated focus on compounding book value per share over decades rather than maximizing near-term earnings.
Why did Markel report a net loss in Q1 2026 if underwriting improved?
+
Markel runs unrealized investment gains and losses through its income statement. In Q1 2026 the insurance combined ratio improved to about 93%, but a swing in investment marks drove a reported net loss of roughly $212 million, illustrating how volatile the headline number can be.
What is the JANA Partners activist campaign about?
+
JANA Partners has publicly urged Markel's board to divest or separate the Markel Ventures unit and launch a roughly $2.0 billion tender offer, arguing the conglomerate structure obscures the value of the core insurance business and weighs on shareholder returns.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell MKL; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.